| Amgros 2027 1.615.b | Amgros I/S | Pfizer ApS, Desitin Pharma A/S, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Abacus Medicine A/S, Abcur AB, +4 | 67,3 mio. kr. (samlet) | 30.10.2026 |
| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Orifarm Generics A/S, STADA Nordic ApS, Viatris ApS, +7 | 102,2 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Sandoz A/S, +7 | 46,2 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 2.691.b | Amgros I/S | Teva Denmark A/S, Krka Sverige AB, Orifarm Generics A/S, Macure Pharma ApS, Takeda Pharma A/S, Strides Nordic ApS, +1 | 48,4 mio. kr. (samlet) | 26.10.2026 |
| Amgros 2027 1.1202.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Orifarm Generics A/S, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Aguettant Nordic ApS, Orifarm A/S, +3 | 381,7 mio. kr. (samlet) | 23.10.2026 |
| Amgros 2027 2.1201.a | Amgros I/S | Paranova Danmark ApS, Orifarm Generics A/S, Pfizer ApS, Gedeon Richter Plc, Orifarm A/S, XGX Pharma ApS, +2 | 128,2 mio. kr. (samlet) | 22.10.2026 |
| Amgros 2027 1.703.b | Amgros I/S | Ferring Lægemidler A/S, Recordati AB, Norgine Danmark A/S, Sandoz A/S, Strides Nordic ApS, Orifarm Generics A/S | 123,4 mio. kr. (samlet) | 14.10.2026 |
| Amgros 2027 1.700.a | Amgros I/S | Macure Pharma ApS, Swedish Orphan Biovitrum AB, Orifarm Generics A/S, Recordati AB, Viatris ApS, Orifarm A/S, +9 | 419,4 mio. kr. (samlet) | 14.10.2026 |
| Amgros 2026 1.12.a | Amgros I/S | FrostPharma AB, Orifarm Generics A/S, Grindeks Kalceks Danmark ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Unimedic Pharma AB, Abcur AB | 34,2 mio. kr. (samlet) | 10.12.2025 |
| Amgros 2026 2.1390.b | Amgros I/S | Viatris ApS, EQL Pharma AB, Orifarm Generics A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, +6 | 23,9 mio. kr. (samlet) | 3.11.2025 |
| Amgros 2026 1.1203.a | Amgros I/S | LEO Pharma A/S, Mundipharma A/S, Pharmanovia A/S, Øresund Pharma ApS, Orifarm Generics A/S, Paranova Danmark A/S, +5 | 368,5 mio. kr. (samlet) | 30.10.2025 |